296 related articles for article (PubMed ID: 22056878)
1. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
Paroni G; Fratelli M; Gardini G; Bassano C; Flora M; Zanetti A; Guarnaccia V; Ubezio P; Centritto F; Terao M; Garattini E
Oncogene; 2012 Jul; 31(29):3431-43. PubMed ID: 22056878
[TBL] [Abstract][Full Text] [Related]
2. All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).
Zanetti A; Affatato R; Centritto F; Fratelli M; Kurosaki M; Barzago MM; Bolis M; Terao M; Garattini E; Paroni G
J Biol Chem; 2015 Jul; 290(29):17690-17709. PubMed ID: 26018078
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.
Centritto F; Paroni G; Bolis M; Garattini SK; Kurosaki M; Barzago MM; Zanetti A; Fisher JN; Scott MF; Pattini L; Lupi M; Ubezio P; Piccotti F; Zambelli A; Rizzo P; Gianni' M; Fratelli M; Terao M; Garattini E
EMBO Mol Med; 2015 Jul; 7(7):950-72. PubMed ID: 25888236
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells.
Fisher JN; Terao M; Fratelli M; Kurosaki M; Paroni G; Zanetti A; Gianni M; Bolis M; Lupi M; Tsykin A; Goodall GJ; Garattini E
Oncotarget; 2015 May; 6(15):13176-200. PubMed ID: 25961594
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers.
Alsafadi S; Even C; Falet C; Goubar A; Commo F; Scott V; Quidville V; Albiges L; Dieci MV; Guegan J; Lazar V; Ahomadegbe JC; Delaloge S; André F
Clin Breast Cancer; 2013 Oct; 13(5):401-8. PubMed ID: 23830798
[TBL] [Abstract][Full Text] [Related]
6. Relationship between retinoic acid receptor alpha gene expression and growth-inhibitory effect of all-trans retinoic acid on canine tumor cells.
Miyajima N; Watanabe M; Ohashi E; Mochizuki M; Nishimura R; Ogawa H; Sugano S; Sasaki N
J Vet Intern Med; 2006; 20(2):348-54. PubMed ID: 16594593
[TBL] [Abstract][Full Text] [Related]
7. Activation of RARα induces autophagy in SKBR3 breast cancer cells and depletion of key autophagy genes enhances ATRA toxicity.
Brigger D; Schläfli AM; Garattini E; Tschan MP
Cell Death Dis; 2015 Aug; 6(8):e1861. PubMed ID: 26313912
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
9. Lapatinib antitumor activity is not dependent upon phosphatase and tensin homologue deleted on chromosome 10 in ErbB2-overexpressing breast cancers.
Xia W; Husain I; Liu L; Bacus S; Saini S; Spohn J; Pry K; Westlund R; Stein SH; Spector NL
Cancer Res; 2007 Feb; 67(3):1170-5. PubMed ID: 17283152
[TBL] [Abstract][Full Text] [Related]
10. The effect pathway of retinoic acid through regulation of retinoic acid receptor alpha in gastric cancer cells.
Liu S; Wu Q; Chen ZM; Su WJ
World J Gastroenterol; 2001 Oct; 7(5):662-6. PubMed ID: 11819850
[TBL] [Abstract][Full Text] [Related]
11. Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells.
Jinno H; Steiner MG; Nason-Burchenal K; Osborne MP; Telang NT
Int J Oncol; 2002 Jul; 21(1):127-34. PubMed ID: 12063559
[TBL] [Abstract][Full Text] [Related]
12. A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer.
Xia W; Bacus S; Hegde P; Husain I; Strum J; Liu L; Paulazzo G; Lyass L; Trusk P; Hill J; Harris J; Spector NL
Proc Natl Acad Sci U S A; 2006 May; 103(20):7795-800. PubMed ID: 16682622
[TBL] [Abstract][Full Text] [Related]
13. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
15. During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein.
Salazar MD; Ratnam M; Patki M; Kisovic I; Trumbly R; Iman M; Ratnam M
Breast Cancer Res; 2011 Feb; 13(1):R18. PubMed ID: 21299862
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E
Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795
[TBL] [Abstract][Full Text] [Related]
17. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
18. Expression, protein stability and transcriptional activity of retinoic acid receptors are affected by microtubules interfering agents and all-trans-retinoic acid in primary rat hepatocytes.
Dvorák Z; Vrzal R; Ulrichová J; Macejová D; Ondková S; Brtko J
Mol Cell Endocrinol; 2007 Mar; 267(1-2):89-96. PubMed ID: 17291686
[TBL] [Abstract][Full Text] [Related]
19. Retinoids and breast cancer: from basic studies to the clinic and back again.
Garattini E; Bolis M; Garattini SK; Fratelli M; Centritto F; Paroni G; Gianni' M; Zanetti A; Pagani A; Fisher JN; Zambelli A; Terao M
Cancer Treat Rev; 2014 Jul; 40(6):739-49. PubMed ID: 24480385
[TBL] [Abstract][Full Text] [Related]
20. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
